ModiQuest focuses on offering high-quality custom antibody generation and development solutions fully tailored to the needs and interests of its clients and partners. Since its creation in 2004, ModiQuest successfully performed over 250 antibody projects for clients in Europe, the US, Asia and Russia.
Over the past 10 years, ModiQuest has built a unique state-of-the-art and fully integrated custom antibody generation and development platform, including antigen design, antibody lead generation, optimization and production. Depending on our clients’ in-house capabilities and the priority and difficulty of their target of interest, they can access the full ModiQuest platform (“from antigen to the production of an optimized antibody”) or choose specific parts of our platform.
Our proprietary flagship antibody generation technologies are ModiFuse™ (electrofusion hybridoma), ModiSelect™ (B-cell selection) and ModiPhage™ (our proprietary fully human and llama, as well as custom-made, phage libraries), for applications in therapeutics, diagnostics and R&D reagent development. These technologies can be applied either separately or in parallel to increase the chance of a successful outcome.
All our services are free of milestone and royalty payments (i.e. full fee-for-service), whereby all intellectual property generated during the execution of contract projects are owned by our clients.